Researchers at the University of Leeds and Lancaster University in the UK have identified a new potential target for the treatment of Alzheimer's disease—PDE4B. Their work is published in Neuropsychopharmacology.
Mar 26, 2024
0
21
A University of Kansas study of rare gene mutations that cause hereditary Alzheimer's disease shows these mutations disrupt the production of a small sticky protein called amyloid.
Feb 29, 2024
0
67
A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.
Feb 22, 2024
0
68
According to the Alzheimer's Association, almost two-thirds of Americans with Alzheimer's dementia are women. While some of this discrepancy can be attributed to women living longer than men on average, researchers believe ...
Feb 20, 2024
0
88
Researchers led by the ESRF, the European Synchrotron, have found that amyloid oligomers play a role in speeding up mitochondrial energetics during the early stages of Alzheimer's, in contrast to what has been previously ...
Dec 14, 2023
0
57
A research team has finally discovered how neurons die in Alzheimer's disease (AD). The team is led by Professor Bart De Strooper at VIB-KU Leuven and the UK Dementia Research Institute (UK DRI) at UCL and Dr. Sriram Balusu ...
Sep 18, 2023
0
83
As many as 5.8 million Americans are currently living with Alzheimer's disease, a neurodegenerative condition associated with progressive cognitive decline, including loss of memory capabilities. Protein aggregates, composed ...
Sep 7, 2023
0
48
Alzheimer's disease is the most common cause of dementia that affects more than 6.5 million Americans, according to the Alzheimer's Association. To find effective treatments and slow the progression of this debilitating disease, ...
Sep 7, 2023
0
52
Researchers at the University of Pittsburgh analyzed thousands of human genomes to find new gene variations responsible for controlling the levels of blood plasma molecules linked to Alzheimer's disease risk. The findings, ...
Sep 6, 2023
0
23
Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines. ...
Jul 13, 2023
0
93
